BBVA USA Bancshares’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$1.47M Buy
3,003
+1
+0% +$501 0.07% 250
2020
Q4
$1.5M Sell
3,002
-14
-0.5% -$6.26K 0.08% 235
2020
Q3
$1.18M Sell
3,016
-53
-2% -$19.6K 0.07% 237
2020
Q2
$1.01M Sell
3,069
-242
-7% -$70.1K 0.06% 257
2020
Q1
$802K Buy
3,311
+135
+4% +$35.2K 0.06% 256
2019
Q4
$830K Buy
+3,176
New +$837K 0.05% 293
2019
Q3
Sell
-3,300
Closed -$909K 440
2019
Q2
$909K Buy
3,300
+405
+14% +$99.8K 0.05% 272
2019
Q1
$648K Buy
2,895
+305
+12% +$63K 0.04% 325
2018
Q4
$481K Sell
2,590
-82
-3% -$16.8K 0.03% 341
2018
Q3
$667K Buy
2,672
+408
+18% +$99K 0.04% 336
2018
Q2
$493K Buy
2,264
+237
+12% +$48.8K 0.03% 372
2018
Q1
$388K Sell
2,027
-41
-2% -$7.57K 0.03% 412
2017
Q4
$323K Sell
2,068
-433
-17% -$68.2K 0.02% 440
2017
Q3
$389K Sell
2,501
-137
-5% -$21.7K 0.03% 412
2017
Q2
$426K Sell
2,638
-196
-7% -$31.8K 0.03% 392
2017
Q1
$438K Sell
2,834
-12
-0.4% -$1.65K 0.03% 389
2016
Q4
$334K Sell
2,846
-25
-0.9% -$2.85K 0.02% 437
2016
Q3
$324K Sell
2,871
-67
-2% -$7.06K 0.02% 442
2016
Q2
$273K Sell
2,938
-82
-3% -$7.04K 0.02% 455
2016
Q1
$237K Buy
+3,020
New +$217K 0.02% 473
2015
Q2
Sell
-2,746
Closed -$212K 524
2015
Q1
$212K Buy
+2,746
New +$214K 0.01% 528

Other funds holding IDXX

BBVA USA Bancshares's IDXX Position: Q1 2021 in Review

BBVA USA Bancshares increased its Idexx Laboratories (IDXX) stake by 0.03% in Q1 2021, buying an estimated $501 and bringing the position to 3,003 shares worth $1.47M. The position accounts for 0.07% of the portfolio, ranked #250.

BBVA USA Bancshares first reported a position in IDXX in Q1 2015 and has held it in 21 quarters since. The position peaked at $1.5M in Q4 2020. 1,012 funds tracked by Wall St. Rank hold IDXX as of Q1 2021.

  • BBVA USA Bancshares held 3,003 shares of Idexx Laboratories worth $1.47M as of Q1 2021.
  • BBVA USA Bancshares bought 1 Idexx Laboratories share in Q1 2021, an estimated $501.
  • Idexx Laboratories made up 0.07% of BBVA USA Bancshares's portfolio in Q1 2021, its #250 holding.
  • BBVA USA Bancshares first reported a position in Idexx Laboratories in Q1 2015 and has held it in 21 quarters since.
  • BBVA USA Bancshares's Idexx Laboratories position peaked at $1.5M in Q4 2020.
  • 1,012 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2021.

Based on BBVA USA Bancshares's 13F filing for Q1 2021, filed 23 Apr 2021.